Conrad Gray’s Post

Do you remember that viral video of a surgical robot stitching a grape back together? That video was uploaded almost 10 years ago. Since then, the field of robotic surgery experienced massive growth in terms of technological capabilities, investments and the number of robots deployed worldwide. These sophisticated medical machines promise to make surgeries less invasive, accelerate the recovery and healing process and enable patients to return to their normal lives more quickly. Surgeons are offered a new way of performing surgeries with robots that provide unprecedented access to the human body and tools that feel like extensions of their own hands. Hospitals can also benefit from increased patient turnaround and from the perception of being at the forefront of medical technology by having some of the most advanced medical devices available. At least that’s what the advocates of surgical robots say. In this article, we will take a deep dive into the world of robotic-assisted surgery, what difference the surgical robots promise to make and what the reality actually looks like. https://lnkd.in/eYJV2T6K #robotics #medicalrobotics #roboticsurgery #medtech

Wondering if robots are revolutionizing surgery? Discover the impact and benefits of robotic assistance in the operating room. Read more: https://lnkd.in/dQhU-Gmn #MedicalTech #Robotics #SurgeryInnovation

Robotic surgery isn't just a futurist concept anymore - it's a booming market with real-world impact, with companies like Intuitive Surgical (ISRG), Medtronic (MDT), and Johnson & Johnson (JNJ) leading the charge in this $18 billion industry. The recent FDA approval of Intuitive Surgical's da Vinci 5 robotic surgery system has created additional buzz. Yet, amidst the excitement, questions arise about product rollout momentum and the competition heating up from Medtronic and Johnson & Johnson. Clarivate medtech experts, April Chan-Tsui and Precia Christian, offer valuable insights into the challenges and opportunities within this pioneering field in a recently published article featured in Investor's Business Daily. Read more, here: https://lnkd.in/g9VXF-6B #Medtech #Robotics #Healthcare

🤖 🦾 In the realm of surgical robotics, two names stand out for their innovation and precision: the da Vinci Surgical System and JingFeng Medical's surgical robots. The da Vinci System, a veteran in the field, has set the gold standard with its advanced robotic platform that allows surgeons to perform minimally invasive procedures with enhanced dexterity and 3D, high-definition vision. Its widespread adoption is a testament to its reliability and the extensive research backing its safety and efficacy. JingFeng Medical, on the other hand, represents the vanguard of a new generation of surgical robotics. Their systems are designed with the latest technological advancements, offering intuitive controls and sophisticated instrumentation that cater to the evolving demands of modern surgery. JingFeng Medical's robots are poised to challenge the status quo, bringing forth innovations that address current limitations and push the boundaries of what's possible in surgical precision and patient care. Both platforms embody the future of surgery, each with its unique strengths and contributions to the field. As we look forward to the continued evolution of surgical robotics. 👍 👍 👍

Ever wondered how robots are transforming surgeries? 🤖🩺 Discover the latest in robotic surgery and its benefits! #HealthcareInnovation #RoboticSurgery Read more: [Do Robots Really Helpful in Surgical?](https://lnkd.in/dQhU-Gmn)

Dr Gareth Blades shares some further thoughts on the transformative impact of robotic surgery: In March, the FDA approved the fifth generation of the market leading robotic assisted surgery system, da Vinci robot made by Intuitive Surgical Inc.    Links to videos below give a glimpse of what is possible with this technology. The new fifth generation da Vinci robot will likely take it a step further.   Robotic assisted surgery is already a large and growing field: Intuitive Surgical's installed base is over 8,600 robots with 2.29m procedures completed in 2023. This means that every minute of the past year ~4 procedures were performed on a da Vinci system. Robotic assisted surgery improves patient outcomes: shorter stays in hospital, fewer complications and faster recovery. This has driven the adoption of robotic surgery, despite its additional cost over traditional open and laparoscopic options.   While granular detail about the new platform hasn't been released, the improvements over the previous generation are impressive. One of the more material upgrades is that the new da Vinci will have 10,000 times more processing power than the last generation. This enables with what the company describes as Surgical Data Science. Surgery video, robot telemetry and patient outcome data collected by the systems will be used to deliver actionable insights to surgeons, their teams and hospital administrations. As an example, surgeons can understand what their better performing peers are doing to achieve faster operations and better patient outcomes. As the data and insight ecosystem builds, the value of these Surgical Data Science applications could accrue to improved total cost of ownership, return on investment and improved patient outcomes.   As more details are released about the fifth generation system, it will be exciting to see how these capabilities progress. If you would like to find out more about robotic assisted surgery, please refer to our recent Amati Insight’s Call from Tuesday 26th March - https://lnkd.in/ew-x5598 'Introducing da Vinci 5: our most advanced and integrated system ever' - https://lnkd.in/gDuhUxmx 'Can AI make surgery safer?' - https://lnkd.in/esKqD2fS #roboticsurgery #healthcareinnovation #surgicaladvancements #davincirobot Warning: Capital at risk. Past performance is not a reliable indicator of future performance.

What is Senhance Surgical Robotics? Senhance Surgical Robotics, developed by Asensus Surgical now owned by KARL STORZ is transforming the future of minimally invasive surgery. Designed to give surgeons greater control while integrating cutting-edge technologies, Senhance combines the precision of robotics with the efficiency of digital laparoscopy. With features like haptic feedback, eye-tracking camera control, and reusable instruments, the system offers a unique blend of innovation and cost-effectiveness that sets it apart from traditional robotic platforms. The technology behind Senhance is focused on enhancing surgeon capabilities while reducing costs. Its haptic feedback provides a sense of touch during surgery, a critical feature for precision. Additionally, eye-tracking camera control allows for hands-free vision adjustment, boosting operational efficiency. With digital laparoscopy and 3D high-definition vision, surgeons experience enhanced depth perception and accuracy in every procedure. Senhance is not only about better technology, but it’s also about improving patient outcomes and making robotic surgery more accessible. By providing a cost-effective solution with reusable instruments and scalable capabilities, it empowers hospitals to adopt advanced surgical robotics without excessive costs. Senhance is redefining the standards of robotic-assisted surgery, paving the way for more efficient and precise operations. #surgicalrobotics #medtech

AI & Robotics in Surgery! ✨🤖 Check out the highlights from our latest blog on how AI-driven robotics are changing the future of surgical care: 🌐 Better Precision: AI helps surgeons achieve unmatched accuracy, reducing complications and improving outcomes. ⏱️ Efficiency Boost: Streamlined procedures mean shorter surgeries and quicker recoveries for patients. 📊 Real-Time Analytics: Surgeons get critical insights instantly, allowing for better decision-making during operations. 🚀 The Future of Patient Care: From robotics to real-time data, this technology sets new standards for safety and precision in the operating room. 👉 Read the blog to learn more about these innovations! https://lnkd.in/dwBn_tQC #HealthcareInnovation #RoboticSurgery #AIinHealthcare #SurgicalPrecision #FutureOfMedicine #Leaniar #MedicalTechnology #Leaniar #UIPath 

🤔 Did you know ... ... 17% of all general surgeries were carried out using robot-assisted procedures in 2022, up from 1.8% in 2012. ... The annual growth rate of surgery procedures performed by robots is 15%. ... 84.2% of urological procedures are robotic in the UK.  ... Worldwide, there are currently 1 million minimally invasive robotic surgeries, which will more than double by 2025. ... The surgical robotics market is expected to reach $22.7 billion in 2030, thanks to novel technology, new market players, and disruptive business models. If this sparked your interest, you might want to check out the 24 most exciting surgical robot companies - or how our very own NVIDIA Holoscan platform is powering real-time applications 😃

Surgical robotics has been a developing field for some time now, but early devices failed to substantially improve patient outcomes over traditional methods. However, after constant iteration and rapid improvements to AI technology, robotic surgery is becoming increasingly viable, offering increased range of motion, enhanced dexterity, and improved ergonomics for surgeons. That said, robotics' high upfront cost, maintenance, and training has dampened adoption rates, and while interest has picked up considerably over the past few years, it will likely be some time before the tech sees widespread adoption. As the technology continues to improve though, its benefits will be difficult to ignore. #SurgicalServices #RoboticSurgery #DigitalTransformation